PetMed Express (NASDAQ:PETS) Shares Cross Above Two Hundred Day Moving Average – What’s Next?

PetMed Express, Inc. (NASDAQ:PETS) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $2.81 and traded as high as $3.06. PetMed Express shares last traded at $2.95, with a volume of 67,631 shares.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PetMed Express in a research note on Monday, December 29th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Sell” and a consensus price target of $3.20.

PetMed Express Stock Down 2.0%

The stock’s 50-day moving average price is $3.28 and its 200 day moving average price is $2.81. The company has a market cap of $63.13 million, a P/E ratio of -0.95 and a beta of 0.70.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Thursday, February 5th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.44). The firm had revenue of $40.66 million during the quarter, compared to analyst estimates of $54.04 million. PetMed Express had a negative net margin of 35.51% and a negative return on equity of 70.81%. Analysts expect that PetMed Express, Inc. will post 0.19 earnings per share for the current fiscal year.

Hedge Funds Weigh In On PetMed Express

Several large investors have recently made changes to their positions in PETS. State Street Corp grew its holdings in PetMed Express by 7.8% in the 4th quarter. State Street Corp now owns 105,173 shares of the company’s stock valued at $337,000 after buying an additional 7,600 shares during the last quarter. Empowered Funds LLC grew its stake in shares of PetMed Express by 14.2% in the fourth quarter. Empowered Funds LLC now owns 68,651 shares of the company’s stock worth $220,000 after acquiring an additional 8,535 shares during the last quarter. Man Group plc increased its position in PetMed Express by 7.1% during the third quarter. Man Group plc now owns 151,039 shares of the company’s stock worth $379,000 after acquiring an additional 9,989 shares during the period. R Squared Ltd acquired a new position in PetMed Express during the 2nd quarter valued at $34,000. Finally, Goldman Sachs Group Inc. boosted its holdings in PetMed Express by 59.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 33,209 shares of the company’s stock valued at $139,000 after purchasing an additional 12,360 shares during the period. Institutional investors and hedge funds own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.